🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

165 results for “Sunshine Biopharma” Clear

  1. HEC585

    Sunshine Biopharma

    Idiopathic Pulmonary Fibrosis

    phase 2 small molecule active

    5 trials

  2. HEC585 dose A

    Sunshine Biopharma

    Progressive Fibrosing Interstitial Lung Disease (PF-ILD) / Progressive Pulmonary Fibrosis (PPF)

    phase 2 small molecule active

    1 trial

  3. HEC96719

    Sunshine Biopharma

    Non-Alcoholic Steatohepatitis

    phase 2 small molecule completed

    1 trial

  4. Injection of humanized nerve growth factor (NGF) antibody

    Sunshine Biopharma

    Cancer Pain

    phase 2 small molecule active

    1 trial

  5. KN046 （PD-L1/CTLA4 BsAb）

    Sunshine Biopharma

    Advanced HCC

    phase 2 small molecule terminated

    1 trial

  6. Recombinant Anti-IL-17A Humanized Monoclonal Antibody Injection

    Sunshine Biopharma

    Psoriasis

    phase 2 small molecule active

    1 trial

  7. Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection 100 mg

    Sunshine Biopharma

    Gout Arthritis

    phase 2 small molecule active

    1 trial

  8. Recombinant Anti-interleukin-4 Receptor Alpha Monoclonal Antibody Injection (611)

    Sunshine Biopharma

    Dermatitis, Atopic

    phase 2 small molecule active

    1 trial

  9. Recombinant Human Erythropoiesis Injection (CHO cell)

    Sunshine Biopharma

    Chronic Renal Failure With Hemodialysis

    phase 2 small molecule active

    1 trial

  10. Recombinant anti-PD-1 humanized monoclonal antibody injection

    Sunshine Biopharma

    Sarcoma, Soft Tissue

    phase 2 small molecule active

    1 trial

  11. SPGL008

    Sunshine Biopharma

    NMIBC

    phase 2 mab active

    1 trial

  12. SSGJ-705

    Sunshine Biopharma

    Locally Advanced, Recurrent or Metastatic Malignancies

    phase 2 small molecule active

    2 trials

  13. SSGJ-706

    Sunshine Biopharma

    First-line Advanced NSCLC Patients

    phase 2 small molecule active

    1 trial

  14. SSGJ-706+XELOX

    Sunshine Biopharma

    Gastric/Gastroesophageal Junction Adenocarcinoma

    phase 2 small molecule active

    1 trial

  15. SSGJ-707

    Sunshine Biopharma

    Metastatic Colorectal Cancer

    phase 2 small molecule active

    1 trial

  16. SSGJ-707

    Sunshine Biopharma

    NSCLC

    phase 2 small molecule active

    1 trial

  17. SSGJ-707

    Sunshine Biopharma

    Advanced/recurrent Endometrial Cancer and Platinum-resistant Ovarian Cancer

    phase 2 small molecule active

    1 trial

  18. SSGJ-707

    Sunshine Biopharma

    First-line Advanced NSCLC Patients

    phase 2 small molecule active

    1 trial

  19. SSS06

    Sunshine Biopharma

    Chemotherapy-induced Anemia

    phase 2 small molecule active

    1 trial

  20. SSS17

    Sunshine Biopharma

    Anemia in Pre-Dialysis Patients

    phase 2 small molecule completed

    1 trial

  21. SSS17 Capsule (6 Dose Levels)

    Sunshine Biopharma

    Postoperative Anemia

    phase 2 small molecule active

    1 trial

  22. Z650

    Sunshine Biopharma

    Esophageal Squamous Cell Carcinoma

    phase 2 small molecule completed

    1 trial

  23. 14028 injection

    Sunshine Biopharma

    Type 2 Diabetes

    phase 1 mab completed

    1 trial

  24. 304 injection

    Sunshine Biopharma

    CD20 Positive B Cell NHL

    phase 1 small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources